Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
Next-generation T-cells-plattform for precision immunomonitoring of autoimmune diseases
| Reference number | 2025-02928 |
| Coordinator | NEOGAP Therapeutics AB |
| Funding from Vinnova | SEK 200 000 |
| Project duration | October 2025 - April 2026 |
| Status | Ongoing |
| Venture | Medtech4Health: Competence Enhancement in SME |
| Call | Medtech4Health: Competence Enhancement in Small Businesses 2025 |
Last updated 16 October 2025
Reference number 2025-02928
